AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
63 hedge funds and large institutions have $94M invested in AVEO Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 24 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
48% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 27
Holders
63
Holding in Top 10
–
Calls
$3.77M
Puts
$3.09M
Top Buyers
| 1 | +$12M | |
| 2 | +$3.41M | |
| 3 | +$3.09M | |
| 4 |
Goldman Sachs
New York
|
+$1.97M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.56M |
Top Sellers
| 1 | -$7.42M | |
| 2 | -$4M | |
| 3 | -$1.83M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.45M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$1.37M |